retatrutide south africa ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial Efficacy and safety of retatrutide,

(2025) Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study

Safety and Efficacy of Glucagon-Like Peptide-1 Receptor Agonists Use in Elderly People With Obesity A Meta-Analysis

Incretin-based therapies for the treatment of non-alcoholic fatty liver disease: a systematic review and meta-analysis

Research is currently underway to see if taking oral weight-loss medication (such as bupropion-naltrexone) can help ease the transition off GLP-1 receptor agonists and reduce the amount of weight that's typically regained after stopping them